CMC1 and urinary bladder cancer: Notably, NK3-CMC1, which was found to be highly expressed in bladder cancer patients, showed elevated levels of TIGIT. TIGIT receptor interactions with its ligands can suppress the cytolytic activity of NK cells, leading to their exhaustion (27,28).